Small supernumerary ring chromosome 6 (sSRC [6] ) is a rare chromosomal abnormality characterized by a broad clinical phenotype. The spectrum of this disorder can range from phenotypically normal to severe developmental delay and congenital anomalies.
We describe two unrelated patients with small SRCs derived from chromosome 6 with a novel bone phenotype. Both patients presented with a complex bone disorder characterized by severe osteopenia, pathologic fractures, and cyst-like lesions within the bone. Imaging revealed decreased bone mineral density, mutiple multiloculated cysts and cortical thinning. Lesion pathology in both patients demonstrated a bland cyst wall with woven dysplastic appearing bone entrapped within it. In patient 1, array comparative genomic hybridization (CGH) detected a tandem duplication of region 6p12.3 to 6q12 per marker chromosome. Cytogenetic analysis further revealed a complex patient of mosaicism with some cell lines displaying either one or two copies of the marker indicative of both tetrasomy and hexasomy of this region. Patient 2 was mosaic for a sSRC that encompassed a 26.8 Mb gain from 6p21.2 to 6q12. We performed an in-depth clinical analysis of a phenotype not previously observed in sSRC(6) patients and discuss the potential influence of genes located within this region on the skeletal presentation observed.
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| INTRODUCTION
A small supernumerary marker chromosome (sSMC) is a rare chromosomal abnormality characterized by presence of cytogenetic content in addition to the normal 46 chromosome karyotype. While the frequencies of these variants are extremely rare, 0.044% (1/2,500) in new born patients, supernumerary marker chromosome 6 has been described in fewer than 35 patients. Majority of sSMC(6) patients are found in conjunction with the presentation of other chromosome abnormalities and to date only 30 patients involving pure sSMC(6) have been described (Aalfs, Jacobs, Nieste-Otter, Hennekam, & Hoovers, 1996; Callen et al., 1991) . This disorder is characterized by a large spectrum of clinical severities that can range from phenotypically normal to a myriad of congenital anomalies. Intrauterine growth retardation (IUGR), mild to severe developmental delay, transient neonatal diabetes mellitus, congenital heart defects, hypotonia, hypogenitalism, hydronephrosis, and vesico-ureteral junction obstruction are clinical features observed in this disorder. Dysmorphic features can include epicanthic folds, thick upper lips, broad nasal bridge and tip, hypertelorism, and prominent cheeks (Huang, Pearle, Rauen, & Cotter, 2012; Liehr et al., 2006; Oldak et al., 2006 ).
Here we report on new clinical symptoms associated with small supernumerary ring marker chromosome 6 in two unrelated patients who both present with severe abnormalities in bone formation and turnover. These patients exhibit cyst-like lesions of the skull, spine and appendicular skeleton, osteopenia and pathologic fracture.
Patient one harbors a complex case of mosaicism with two copies of 6p12.3-q12 per ring chromosome. Cytogenetic analysis revealed mosaicism for both one and two copies of this sSRC(6), indicating both tetrasomy and hexasomy of this region that has not been previously described in literature. Patient 2 presents with a mosaic sSRC(6) encompassing 6p21.2-6q12. Comparison with current literature on sSMC(6) failed to exhibit any patients noted with bone abnormalities. We propose expansion of the phenotype observed in patients with sSMC(6).
Patient 1 is an 18-year old Caucasian male who was the fourth pregnancy to a non consanguineous couple. Maternal history of pregnancy is not known. His family history was significant for multiple fractures with relatively trivial trauma in his mother. She died in a minor car accident from multiple craniofacial fractures and family reports that she had issues with bone fragility and multiple fractures. Pregnancy, labor, and delivery were unremarkable and birth weight was 4.41 kg (90-95%). Other birth parameters are not known. Early medical history was notable for reactive airway disease, bronchiolitis, and 6 weeks of vomiting around 1 year of age. Both of which resolved over time.
Patient 1 was initially examined at our institute when he was 10 years old following complaint of back pain from a fall. Physical examination was negative for dysmorphic features, however a bluish tint to the sclera was observed. At the present time, mild developmental delays were noted with a failure to read until third grade.
He had a history of bone fragility and four prior fractures. He had a femur fracture at age 2 years, a right arm fracture, a left hand fracture, as well as, a rib fracture and back pain (Figures 1a and 1c) . Imaging revealed severe osteopenia, pathologic compression fractures, and numerous cystic lesions throughout the spine (Figure 1c ). An initial bone density scan was performed and this study demonstrated a whole body Z-score of −1.1 with a lumbar spine Z-score of −2.6.
A subsequent bone scan revealed fracture of the right eighth rib, T8 vertebral body, and ankles bilaterally. Laboratory studies determined 
| Patient 2
Patient 2 is a 14 year old male born at 40 weeks gestation to a 25-year-old G3P2 mother weighing 2.21 kg. There is no significant family history of bone abnormalities. He presented prenatally when the mother screened positive for elevated levels of serum alpha feto protein (AFP). Amniocentesis showed a normal amniotic fluid AFP, but identified a mosaic supernumerary ring chromosome (47, XY, +mar[12]/46, XY[3] ). He was noted at birth to be dysmorphic with IUGR and was discharged at 2 days of age. At 2 months of age he was placed with a G-tube due to poor feeding and vomiting. The subsequent course was marked by seizures, visual and developmental delays, particularly in speech, hydronephrosis, and reoccurring otitis media.
Craniofacial dysmorphism consisted of biparietal prominence, bitemporal narrowing, asymmetry and coronal indentations, high nasal bridge, deep-set eyes, thin upper lips, and microglossia. He presented with amblyopia and latent nystagmus upon ophthalmological examination.
Evaluation at 9 years of age showed a height of 123 cm (3%), weight of 30 kg (55%) and a head circumference of 51.5 cm (25%). He no longer used a G-tube for feeding but reported frequent vomiting once or twice a day due to oral phase dysphagia. He had persistent absence seizures and continued to have gross motor and developmental delays with decreased balance and frequent falling. Some urinary incontinence was observed that was improved with tethered cord surgery. There was also mild conductive hearing loss.
Orthopedic evaluation showed marked cystic changes and severe osteopenia through his spine, pelvis, and proximal femurs. His entire spine has fishtail deformities of the vertebrae as well as intervertebral disks that have invaginated into the bone above and below (Figure 1d Fractures were observed in the left femoral neck and he was placed on pamidronate therapy, however there was no definite 
| DISCUSSION
We report on two unrelated patients with sSRC(6) that results in severe osteopenia, cystic lesions involving the skull, spine and appendicular skeleton, and frequent, pathologic fractures. At least 14 patients with pure supernumerary chromosome 6 abnormalities have been described FIGURE 3 GTG banding analysis for (a) patient 1 and (b) patient 2 exhibiting small supernumerary ring chromosomes (sSRC). FISH analysis further confirmed presence of a sSRC of pure chromosome 6 origin with an 18.2 and 26.8 Mb gain in patient 1 and patient 2, respectively encompassing regions similar to our patients described here and there are no reports of bone abnormalities (http://ssmc-tl.com/chromosome-6.html#sym). Our patient 1 has a duplicated 18.25 Mb gain encompassing 6p12.3-q12 and a complex case of tetrasomy and hexasomy of the duplicated region. Patient 2 has a ring chromosome that encompasses 6p21.2-q12. In reported sSMC(6) with clinical manifestations, a positive course is most commonly marked by facial dysmorphism, congenital heart defects, feeding difficulties, and various neurological deficiencies such as psychomotor delay, epilepsy, or abnormal behavior. A patient with sSMC encompassing 6p21.2-q11.2 presented with IUGR, severe developmental delay, facial dysmorphism, scoliosis, lax joints, and transient neonatal diabetes (Crolla, Howard, Mitchell, Long, & Dennis, 1997 ). An additional patient with a 6p21.2-q11.2 sSMC was described with IUGR, facial dysmorphism, developmental delay, and epilepsy (Huang et al., 2012) . The remaining patients of characterized sSMC6 consist of small duplicated regions encompassing 6p11.1-q12. Phenotypic severity consists of psychomotor delay, hypotonia, congenital heart defects, and facial dysmorphism to phenotypically normal (Huang et al., 2012; Leite et al., 2006; Liehr et al., 2006; Oldak et al., 2006; Stankiewicz et al., 2000) . Intriguingly, this bone phenotype has been described once before. Reoccurring cyst formation associated with pathologic fracture was observed in a suspected osteogenesis imperfecta (OI) patient (Stig, 1997) which is suggestive of a similar chromosomal abnormality to our patients.
There is a large spectrum of clinical phenotypes observed in patients with marker chromosomes and sSMC's consisting of similar cytogenetic content can manifest with extreme phenotypic variability. While there are some genotype-phenotype correlations observed in sSMC(6) cohorts, we did not observe any reports of pathologic fracture or bone cyst formation in any other patients with sSMC(6). Phenotypic effects of sSMC's are largely multifactorial and can depend on the whether the marker is de novo or familial, the size of the marker, presence of UPD and the extent of euchromatin material within the marker. Marker mosaicism adds an additional layer of complexity. Precise tissue distribution of the sSMC and extent of expression within these tissues can all play a role in the clinical manifestations observed in our patients.
There are over 75 genes within the region of overlap in these two patients (Figure 4) . Several of which have been associated with bone development and maintenance. An elevated alkaline phosphatase level in both of our patients alludes to increased bone formation and turnover. Runt-related transcription factor 2 (RUNX2) is a major regulator of bone formation and osteoblast differentiation and is close in proximity to the region of duplication. Increased Runx2 activity is associated with pathologic bone formation in radial cysts (Kusafuka, Sasaguri, Sato, Takemura, & Kameya, 2006) and mutations in RUNX2 cause Cleidocranial dysplasia (OMIM 119600) and metaphyseal dysplasia with maxillary hypoplasia (OMIM 156510) (Mundlos et al., 1997) . Translocation associated membrane protein 2 (TRAM2) is also found in the sSRC region and is integral in the late stages of osteoblastogenesis and its activity can be regulated by Runx2. (Pregizer, Barski, Gersbach, Garcia, & Frenkel, 2007) . Altered RUNX2 and TRAM2 expression could play a role in the profuse osteopenia and increased bone turnover observed in these patients.
FIGURE 4
Comparison of genes found within the sSRC(6) in patient 1 and patient 2 (adapted from UCSC). Overlapping regions of interest are denoted between 37, 216, 424 and 64, 096, 485 GRCh37 (hg19) . Original coordinates provided at the time of testing were updated to GRCh37 (hg19) build. [Color figure can be viewed at wileyonlinelibrary.com]
In addition to key regulators of bone formation and development, several pro-inflammatory cytokines are found within the duplicated region. Pro-inflammatory cytokines within this region include, Tumor Necrosis Factor Receptor Superfamily, member 21 (TNFRSF21), interleukin 17F (IL-17F), and interleukin 17A (IL-17A). IL-17A can increase proliferation of mesenchymal stem cells (Huang, La Russa, Alzoubi, & Schwarzenberger, 2006) and enhance bone loss via osteoclastic bone resorption (Won et al., 2011) . Dysregulation of inflammatory cytokines could play a role in progression of pathologic fracture through upregulation of osteoclast activity and elevated inflammation resulting in cystic lesions.
Our report describes novel clinical symptoms associated with sSRC(6). The overlapping region in both of our patients consists of several important genes involved in bone development, bone maintenance, and inflammation. We hypothesize that a combination of dysregulation of critical genes involved in bone development via RUNX2, TRAM2 and inflammatory pathways involving IL-17A contribute to pathology of disease. We propose an expansion of the phenotype associated with sSMC(6) and our clinical data supports the importance of this region 6p12.3-q12 in the normal development and maintenance of bone.
